Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Polypoidal choroidal vasculopathy: Which Medications Are Safest? (28 Drugs Compared)

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

28 medications are used for Polypoidal choroidal vasculopathy, with 692 combined adverse event reports. The most reported drugs for Polypoidal choroidal vasculopathy are RANIBIZUMAB and VERTEPORFIN.

692
Total Reports
28
Drugs Used

All Medications for Polypoidal choroidal vasculopathy Ranked by Safety Reports

Drug Brand Reports Deaths (all) Hosp. (all) Death Rate
RANIBIZUMAB CIMERLI 315 2,651 2,265 17.3%
VERTEPORFIN Visudyne 210 19 46 2.5%
AFLIBERCEPT EYLEA 193 8,527 3,193 31.7%
BROLUCIZUMAB BEOVU 70 41 105 6.0%
BROLUCIZUMAB-DBLL - 64 198 170 7.1%
BEVACIZUMAB JOBEVNE 46 17,498 23,114 22.4%
FARICIMAB\FARICIMAB-SVOA - 43 97 79 2.9%
FLUOROURACIL FLUOROURACIL 17 6,997 20,941 13.2%
IRINOTECAN Irinotecan Hydrochloride 17 4,530 10,384 16.2%
LEUCOVORIN LEUCOVORIN CALCIUM 17 3,932 10,039 15.7%
LUCENTIS - 7 184 180 26.8%
FARICIMAB-SVOA - 5 175 169 9.2%

View all 28 drugs →

Most Reported Drugs for Polypoidal choroidal vasculopathy

#1 most reported
#2 most reported
#3 most reported